- Home
- INAB vs IPA Comparison
INAB vs IPA Comparison
Compare INAB & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- IPA
- Stock Information
- Founded
- INAB 2016
- IPA 1983
- Country
- INAB United States
- IPA United States
- Employees
- INAB N/A
- IPA N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- INAB Health Care
- IPA Health Care
- Exchange
- INAB Nasdaq
- IPA Nasdaq
- Market Cap
- INAB 14.5M
- IPA 20.6M
- IPO Year
- INAB 2021
- IPA 2017
- Fundamental
- Price
- INAB $0.16
- IPA $0.45
- Analyst Decision
- INAB Strong Buy
- IPA Strong Buy
- Analyst Count
- INAB 2
- IPA 2
- Target Price
- INAB $3.60
- IPA $4.00
- AVG Volume (30 Days)
- INAB 609.1K
- IPA 407.1K
- Earning Date
- INAB 05-07-2025
- IPA 03-28-2025
- Dividend Yield
- INAB N/A
- IPA N/A
- EPS Growth
- INAB N/A
- IPA N/A
- EPS
- INAB N/A
- IPA N/A
- Revenue
- INAB N/A
- IPA $16,581,105.00
- Revenue This Year
- INAB N/A
- IPA $4.67
- Revenue Next Year
- INAB N/A
- IPA $14.15
- P/E Ratio
- INAB N/A
- IPA N/A
- Revenue Growth
- INAB N/A
- IPA 1.34
- 52 Week Low
- INAB $0.13
- IPA $0.27
- 52 Week High
- INAB $1.74
- IPA $1.36
- Technical
- Relative Strength Index (RSI)
- INAB 36.75
- IPA 52.32
- Support Level
- INAB $0.15
- IPA $0.45
- Resistance Level
- INAB $0.17
- IPA $0.48
- Average True Range (ATR)
- INAB 0.01
- IPA 0.03
- MACD
- INAB 0.00
- IPA 0.00
- Stochastic Oscillator
- INAB 3.17
- IPA 55.57
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.